zeus 888ZEUS will evaluate the effect of ziltivekimab on MACE and kidney outcomes in participants with CKD, ASCVD, and elevated hsCRP levels, as well as additionalZEUS will evaluate the effect of ziltivekimab on MACE and kidney outcomes in participants with CKD, ASCVD, and elevated hsCRP levels, as well as additional